(Press-News.org) EDITOR'S PICK: Selective estrogen signaling key to postmenopausal risk of obesity
The hormone estradiol-17-beta is a key reproductive hormone. However, it also contributes to the regulation of energy balance and body weight. As a result, estrogen deficiency following menopause is associated with an increased probability of obesity and increased risk for developing type 2 diabetes. A team of researchers, led by Jon Levine, at Northwestern University, Evanston, has now generated new insight into the mechanisms by which ER-alpha signaling maintains normal energy balance. Specifically, the team found that nonclassical ER-alpha signaling is key to the effects of estradiol-17-beta on energy balance. These data lead them to suggest that it might be possible to develop drugs that selectively activate nonclassical ER-alpha signaling to reduce the risks of obesity and metabolic disturbances in postmenopausal women.
TITLE: Genetic rescue of nonclassical ER-alpha signaling normalizes energy balance in obese Er-alpha-null mutant mice
AUTHOR CONTACT:
Jon E. Levine
Northwestern University, Evanston, Illinois, USA.
Phone: 847.491.7180; Fax: 847.491.5211; E-mail: jlevine@northwestern.edu.
View this article at: http://www.jci.org/articles/view/41702?key=e6c0c5e6b4574e440bcb
NEUROBIOLOGY: Propagating a characteristic of Parkinson disease
The nerve cells affected in individuals with Parkinson disease are characterized by the presence of structures known as Lewy bodies, which are primarily composed of aggregated α-synuclein (α-syn). Recent data, have suggested that α-syn can be transferred between neurons and that this propagates disease. A team of researchers, led by Patrik Brundin, at Lund University, Sweden, has now tested this hypothesis in several coculture systems and in vivo models, generating data that indicate that it is a key element in the progression of Parkinson disease pathology.
TITLE: Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
AUTHOR CONTACT:
Patrik Brundin
Wallenberg Neuroscience Center, Lund University, Lund, Sweden.
Phone: 46.46.222.05.29; Fax: 46.46.222.05.31; E-mail: patrik.brundin@med.lu.se.
View this article at: http://www.jci.org/articles/view/43366?key=468fe7ace80555577388
TRANSPLANTATION: Identifying the immune cell barrier to fetal stem cell transplantation
It is hoped that stem cell transplantation might provide a new approach to treat inherited disorders. However, this approach is currently limited by graft rejection and the need to persistently use immunosuppressive drugs to prevent graft rejection. Transplantation of genetically correct stem cells from a genetically nonidentical individual into the early gestational fetus, a treatment termed in utero hematopoietic cell transplantation (IUHCTx), could potentially overcome these limitations. However, clinical use of IUHCTx has been hampered by poor engraftment. Tippi MacKenzie, Qizhi Tang, and colleagues, at UCSF, San Francisco, have now determined that in mice maternal immune cells known as T cells are the main barrier to engraftment following IUHCTx. When the graft used for the IUHCTx was matched to the mother, engraftment was markedly enhanced, leading the authors to suggest that the clinical success of IUHCTx may be improved by transplanting cells matched to the mother.
TITLE: Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice
AUTHOR CONTACT:
Tippi C. MacKenzie
University of California, San Francisco, San Francisco, California, USA.
Phone: 415.476.4086; Fax: 415.476.2314; E-mail: Tippi.Mackenzie@ucsfmedctr.org.
Qizhi Tang
University of California, San Francisco, San Francisco, California, USA.
Phone: 415.476.1739; Fax: 415.502.8326; E-mail: Qizhi.Tang@ucsfmedctr.org.
View this article at: http://www.jci.org/articles/view/44907?key=03da42265642f0ef600c
TUMOR IMMUNOLOGY: New immune cell activator protects mice from cancer
Activation of immune cells known as iNKT cells has been shown to protect against cancer in animal models. In these studies, iNKT cell activation is achieved using a molecule known as alpha-GalCer and protection is mediated primarily by the immune molecule IFN-gamma. However, a team of researchers, led by Jay Berzofsky and Masaki Terabe, at the National Institutes of Health, Bethesda, has now identified a new iNKT cell activator that protects mice from tumors through an IFN-gamma–independent mechanism. As this new activator (beta-ManCer) synergized with alpha-GalCer to protect mice against tumors, the authors suggest that similar treatments may provide protection against tumors in humans.
TITLE: Mouse and human iNKT cell agonist beta-mannosylceramide reveals a distinct mechanism of tumor immunity
AUTHOR CONTACT:
Jay A. Berzofsky
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Phone: 301.496.6874; Fax: 301.480.0681; E-mail: berzofsk@helix.nih.gov.
Masaki Terabe
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Phone: 301.435.8349; Fax: 301.402.0549; E-mail: terabe@mail.nih.gov.
View this article at: http://www.jci.org/articles/view/42314?key=1e385deea396d3927571
VIROLOGY: Homing in on the virus-infected cells that cause a fatal B cell tumor
Multicentric Castleman disease (MCD) and primary effusion lymphoma (PEL) are fatal tumors; current treatments prolong survival by a few years at best. These tumors arise from immune cells known as B cells and are caused by Kaposi sarcoma–associated herpesvirus (KSHV). Little is known about the identity of the B cell subtypes most susceptible to infection by KSHV, information that would provide invaluable insight into the development of these fatal tumors. In this context, Dean Kedes and colleagues, at the University of Virginia Health Systems, Charlottesville, have now identified a subset of human tonsillar cells as susceptible to infection with KSHV. Their data lead them to suggest that KSHV latently (silently) infects tonsillar IgM-lambda-expressing B cells, which then proliferate and acquire characteristics similar to those of the tumor cells in individuals with MCD.
TITLE: KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation
AUTHOR CONTACT:
Dean H. Kedes
University of Virginia Health Systems, Charlottesville, Virginia, USA.
Phone: 434.243.2758; Fax: 434.982.1071; E-mail: kedes@virginia.edu.
View this article at: http://www.jci.org/articles/view/44185?key=890327e6501c6461d6e7
###
JCI online early table of contents: Jan. 18, 2011
2011-01-19
ELSE PRESS RELEASES FROM THIS DATE:
Watching others smoke makes smokers plan to light up
2011-01-19
Seeing actors smoke in a movie activated the brain areas of smokers that are known to interpret and plan hand movements, as though they too were about to light a cigarette, according to a new study in the Jan. 19 issue of The Journal of Neuroscience.
Habitual smokers repeat the same hand motions, sometimes dozens of times a day. In this study, researchers led by senior investigator Todd Heatherton, PhD, and graduate student Dylan Wagner of Dartmouth College set out to determine whether the parts of the brain that control that routine gesture could be triggered ...
NSAID receptor responsible for olive oil's 'cough' and more
2011-01-19
PHILADELPHIA (January 18, 2011) – Scientists from the Monell Center and collaborators report that a receptor known as TRPA1 is activated by two structurally unrelated anti-inflammatory compounds. The first, oleocanthal, is a natural polyphenolic anti-inflammatory agent uniquely found in extra virgin olive oil; while the second, ibuprofen, is an over-the-counter non-steroidal anti-inflammatory drug (NSAID).
The researchers also demonstrate that the TRPA1 receptor is spatially localized to the back of the throat, which is exactly where the distinctive irritating sting ...
Use of antidepressant associated with reduction in menopausal hot flashes
2011-01-19
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.
"Hormonal agents have been the predominant therapy for menopausal hot flashes, but their use decreased substantially following the shifts in risk-benefit ratios that were identified in the Women's Health Initiative Estrogen plus Progestin randomized controlled trial. ...
Lower biomarker levels, less education associated with greater cognitive decline
2011-01-19
Older adults without dementia and with lower levels in plasma of the biomarkers beta-amyloid 42/40 (protein fragments) had an increased rate of cognitive decline over a period of 9 years, according to a study in the January 19 issue of JAMA. The researchers also found that this relationship was stronger among individuals with less education and lower levels of literacy.
An estimated 36 million people currently have dementia, with the prevalence expected to double every 20 years, according to background information in the article. "Thus, biomarkers to identify elderly ...
Imaging procedure can identify biomarker associated with Alzheimer's disease
2011-01-19
Preliminary research suggests that use of a type of molecular imaging procedure may have the ability to detect the presence of beta-amyloid in the brains of individuals during life, a biomarker that is identified during autopsy to confirm a diagnosis of Alzheimer disease, according to a study in the January 19 issue of JAMA.
"Both diagnosis and treatment of Alzheimer disease (AD) are hampered by the lack of noninvasive biomarkers of the underlying pathology. Between 10 percent and 20 percent of patients clinically diagnosed with AD lack AD pathology at autopsy, and community ...
Big city life may make residents lean toward green, study says
2011-01-19
EAST LANSING, Mich. – The downsides of China's explosive urbanization – like pollution and greenhouse gas emissions – now are joined by an upside: Better environmental citizens.
It's the first time scientists have weighed employment and leadership when considering environmental behavior in China's cities. In the latest online edition of the British journal Environmental Conservation, scientists at the Center for Systems Integration and Sustainability at Michigan State University and collaborators in the U.S. and China show that city size – especially the good jobs there ...
Mother's stem cells likely key to treating genetic disease before birth
2011-01-19
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth. Through a series of mouse model experiments, the research team determined that a mother's immune response prevents a fetus from accepting transplanted blood stem cells, and yet this response can be overcome simply by transplanting cells harvested from the mother herself.
"This research is really exciting because it offers us a straightforward, elegant solution that makes fetal stem ...
Scientists: Big city life may alter green attitudes
2011-01-19
People with good jobs found in large cities are more likely to engage in pro-environmental activities. So says a new study of China's environmental behavior published this week in the British journal Environmental Conservation.
For the first time, scientists weighed employment and leadership when considering how people act regarding their natural surroundings. They found the status and political power of companies in cities such as Beijing, Shanghai and Tianjin strongly influence the conservation practices of their employees.
Moreover, the scientists found employees ...
Standardized screening rule for TB in people living with HIV in low income settings
2011-01-19
Standardized screening rule for TB in people living with HIV in low income settings
In 2009, 1.7 million people died from TB— which translates to 4700 deaths a day—including 380, 000 people living with HIV. TB remains the most common cause of death in people living with HIV. This week in PLoS Medicine, Haileyesus Getahun (WHO) and colleagues report the development of a simple, standardized tuberculosis (TB) screening rule for resource-constrained settings, to identify people living with HIV who need further investigation for TB disease. The results of this study, which ...
A new method to correct mortality rate biases in HIV treatment programs
2011-01-19
HIV treatment programs in sub-Saharan Africa should routinely report mortality rates among patients who remain in the programs and those patients lost to follow-up, according to a study by Matthias Egger and colleagues from the International Epidemiologic Databases to Evaluate AIDS in East Africa, Western Africa, and Southern Africa that is published in this week's PLoS Medicine. As a substantial proportion of patients in HIV treatment programs are lost to follow-up, mortality estimates for patients in these programs can be severely underestimated, so this bias needs to ...